Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bleomycin (blenoxane) (1 trial)
dacarbazine (dtic-dome) (1 trial)
doxorubicin (Doxil) (1 trial)
rituximab (rituxan) (1 trial)
vinblastine (velban) (1 trial)
Hodgkin Disease (Phase 3)
Lymphoma (Phase 3)
Trials (1 total)
Trial APIs (5 total)